Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 12, 2010, Pages 6118-6124

  Falsini, Benedetto ^a   Piccardi, Marco ^a   Minnella, Angelo ^a   Savastano, Cristina ^a   Capoluongo, Ettore ^b   Fadda, Antonello ^c   Balestrazzi, Emilio ^a   Maccarone, Rita ^d   Bisti, Silvia ^d,e,f  

^a Dipartimento di Scienze Oftalmologiche and Otorinolaringologiche   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e Australian Government Australian Research Council   (Australia)

^f NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTENOID; PLACEBO; SAFFRON; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; AMPLITUDE MODULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ELECTRORETINOGRAM; FEMALE; FREQUENCY MODULATION; HUMAN; MALE; NEUROPROTECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; SENSITIVITY ANALYSIS; SPECTRAL SENSITIVITY; VISUAL ACUITY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; CROCUS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTRORETINOGRAPHY; FEMALE; FLICKER FUSION; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHYTOTHERAPY; PROSPECTIVE STUDIES; RETINA;

EID: 77956979629     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4995     Document Type: Article

References (40)

1. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and agerelated macular degeneration: the International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367-374.
2. Evans RJ. Risk factors for age-related macular degeneration. Prog Retin Eye Res. 2001;20:227-253.
3. Gartner S, Henkind P. Aging and degeneration of the human macular: 1. Outer nuclear layer and photoreceptors. Br J Ophthalmol. 1981;65:23-28.
4. Johnson PT, Lewis GP, Talaga KC, et al. Drusen-associated degeneration in the retina. Invest Ophthalmol Vis Sci. 2003;44:4481-4488.
5. Owsley C, Jackson GR, White M, Feist R, Edwards D. Delays in rod-mediated dark adaptation in early age-related maculopathy. Ophthalmology. 2001;108:1196-1202.
6. Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology. 2002;109:1235-1242.
7. Jackson GR, McGwin G Jr, Phillips JM, Klein R, Owsley C. Impact of aging and age-related maculopathy on activation of the a-wave of the rod-mediated electroretinogram. Invest Ophthalmol Vis Sci. 2004;45:3271-3278.
8. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Foveal flicker sensitivity discriminates ARM-risk from healthy eyes. Invest Ophthalmol Vis Sci. 1992;33:3143-3149.
9. Mayer MJ, Spiegler SJ, Ward B, Glucs A, Kim CB. Preliminary evaluation of flicker sensitivity as a predictive test for exudative age-related maculopathy. Invest Ophthalmol Vis Sci. 1992;33: 3150-3155.
10. Phipps JA, Guymer RH, Vingrys AJ. Loss of cone function in age-related maculopathy. Invest Ophthalmol Vis Sci. 2003;44: 2277-2283.
11. Goldberg J, Flowerdew G, Smith E, et al. Factors associated with age-related macular degeneration: an analysis of data from the First National Health and Nutrition Survey. Am J Epidemiol. 1988;128: 700-710.
12. Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced agerelated macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009;50(5): 2044-2053.
13. Shen JK, Dong A, Hackett SF, Bell WR, Green WR, Campochiaro PA. Oxidative damage in age-related macular degeneration. Histol Histopathol. 2007;22:1301-1308.
14. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr. 1995;62 (suppl):1448S-1461S.
15. Landrum JT, Bone RA, Joa H, et al. A one year study of the macular pigment: the effect of 140 days of a lutein supplementation. Exp Eye Res. 1997;65:57-62.
16. Cai J, Nelson KC, Wu M, et al. Oxidative damage and protection of RPE. Prog Retin Eye Res. 2000;19:205-221.
17. Hammond BR, Fuld K, Snodderly MD. Iris color and macular pigment optical density. Exp Eye Res. 1996;62:715-720.
18. Chucair AJ, Rotstein NP, Sangiovanni JP, During A, Chew EY, Politi LE. Lutein and zeaxanthin protect photoreceptors from apoptosis induced by oxidative stress: relation with docosahexaenoic acid. Invest Ophthalmol Vis Sci. 2007;48(11):5168-5177.
19. Klein ML, Francis PJ, Rosner B, et al. CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology. 2008;115:1019-1025.
20. Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH. Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis (review). BMJ. 2007;335(7623):755.
21. Kirschfeld K. Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc Royal Soc (Lond). 1982;216:71-85.
22. Schalch W. Carotenoids in the retina-A review of their possible role in preventing or limiting damage caused by light and oxigen. In: Emerit I, Chance B, eds. Free Radicals and Aging. Basel, Switzerland: Birkhauser and Verlag; 1992;280-298.
23. Falsini B, Piccardi M, Iarossi G, Fadda A, Merendino E, Valentini P. Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment. Ophthalmology. 2003;110(1):51-60, discussion 61.
24. Richer S, Stiles W, Statkute L, et al. Double-masked, placebocontrolled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75(4):216-230.
25. Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S. CARMISStudy Group. Carotenoids and antioxidants in Age-Related Maculopathy Italian Study: multifocal electroretinogram modifications after 1 year. Ophthalmology. 2008;115(2):324-333.e2.
26. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
27. Maccarone R, Di Marco S, Bisti S. Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Invest Ophthalmol Vis Sci. 2008;49:1254-1261.
28. Falsini B, Fadda A, Iarossi G, et al. Retinal sensitivity to flicker modulation: reduced by early age-related maculopathy. Invest Ophthalmol Vis Sci. 2000;41:1498-1506.
29. The Age-Related Eye Disease Study Research Group. The agerelated eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report no. 6. Am J Ophthalmol. 2001;132:668-681.
30. Seiple WH, Holopigian K, Greenstein VC, Hood DC. Sites of cone system sensitivity loss in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1993;34(9):2638-2645.
31. Seiple W, Holopigian K, Greenstein V, Hood DC. Temporal frequency dependent adaptation at the level of the outer retina in humans. Vision Res. 1992;32(11):2043-2048.
32. Fiorentini A, Maffei L, Pirchio M, Spinelli D, Porciatti V. The ERG in response to alternating gratings in patients with diseases of the peripheral visual pathway. Invest Ophthalmol Vis Sci. 1981;21: 490-493.
33. Kondo M, Sieving PA. Primate photopic sine-wave flicker ERG: vector modeling analysis of component origins using glutamate analogs. Invest Ophthalmol Vis Sci. 2001;42:305-312.
34. Giaccio M. Crocetin from saffron: an active component of an ancient spice. Crit Rev Food Sci Nutr. 2004;44:155-172.
35. Ochiai T, Shimeno H, Mishima K, et al. Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim Biophys Acta. 2007;1770(4):578-584.
36. Laabich A, Vissvesvaran GP, Lieu KL, et al. Protective effect of crocin against blue light- and white light-mediated photoreceptor cell death in bovine and primate retinal primary cell culture. Invest Ophthalmol Vis Sci. 2006;47(7):3156-3163.
37. Kanakis CD, Tarantilis PA, Polissiou MG, Diamantoglou S, Tajmir-Riahi HA. An overview of DNA and RNA bindings to antioxidant flavonoids. Cell Biochem Biophys. 2007;49(1):29-36.
38. Hollyfield JG, Bonilha VL, Rayborn ME, et al. Oxidative damageinduced inflammation initiates age-related macular degeneration. Nat Med. 2008;14(2):194-198.
39. Fish GE, Birch DG. The focal electroretinogram in the clinical assessment of macular disease. Ophthalmology. Jan 1989;96(1): 109-114.
40. Curcio CA, Medeiros NE, Leigh Millican C. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37:1236-1249.